ArticleCureus2025
Challenges in Diagnosing Opsoclonus-Myoclonus Syndrome in Adults.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opsoclonus-myoclonus syndrome (OMS) is a rare neurological condition characterised by uncontrolled eye movements and myoclonus. The pathophysiology is autoimmune, usually due to a paraneoplastic or parainfectious cause. Studies on adult-onset OMS are not extensive, and the lack of awareness contributes to the challenge of its diagnosis. A 37-year-old female presented with nausea, dizziness, chaotic eye movements, and wide gait. Blood tests and imaging were unremarkable, but positive oligoclonal bands and elevated protein were seen in the cerebrospinal fluid analysis. She received betahistine and ondansetron as symptomatic treatment and was diagnosed with OMS. She was treated with intravenous immunoglobulin and had a slow, incomplete recovery with residual uncontrolled eye movements. A month before her presentation, she had been seen by the General Practitioner, was treated with antiemetics, and was referred to ENT. This case illustrates the importance of awareness of OMS in avoiding delay in diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.